Browse by author
Lookup NU author(s): Rodrigo Figueiredo,
Dr Colin Wilson
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Organ transplantation provides both life-saving and life-enhancing function for patients suffering from end-stage organ failure. Transplantation has only been possible due to the advances in immunosuppression. The viability of a transplanted organ depends on modulation of the human immune system to avoid rejection in response to foreign antigens. Modern immunosuppression consists of multi-modal therapy (chemical drugs and biological agents) acting on different parts of the immune response. Three phases of immunosuppression can be recognized: induction, maintenance and withdrawal. All patients must continue to take at least some immunosuppression to prevent rejection. Developments in immunosuppressant regimens have dramatically improved transplant success rates and experience over the years has helped to understand the side-effects and long-term complications of immunosuppression. Research continues to identify both novel compounds and ways of optimizing the use of current drugs. © 2014 Elsevier Ltd. All rights reserved.
Author(s): Figueiredo RS, Wilson C
Publication type: Review
Publication status: Published
Print publication date: 01/07/2014
Online publication date: 14/06/2014
Acceptance date: 01/01/1900
ISSN (print): 0263-9319
ISSN (electronic): 1878-1764
Publisher: Elsevier Ltd